Search research articles
Contact Us
Filters
Showing results (211-220 of 231) with videos related to
Page
of 24
Sort By:
Cancers
|
June 10, 2023
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, et al.
Antiviral Therapy
|
February 7, 2017
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens
Nicola Coppola, Stefania De Pascalis, Vincenzo Messina, et al.
Diabetes Research and Clinical Practice
|
September 5, 2025
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 21, 2023
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
Riccardo Nevola, Giovanni Feola, Rachele Ruocco, et al.
BMC Medicine
|
March 3, 2026
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
Frontiers in Oncology
|
May 16, 2020
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study
Massimiliano Berretta, Luca Rinaldi, Rosaria Taibi, et al.
European Heart Journal. Imaging Methods and Practice
|
November 21, 2025
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use
Raffaele Marfella, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
International Journal of Molecular Sciences
|
October 29, 2025
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study
Celestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
Drugs in Context
|
January 7, 2021
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study
Rodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, et al.
Cancers
|
June 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis
Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 231) with videos related to
Sort By:
Page
of 24
Cancers
|
June 10, 2023
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, et al.
Antiviral Therapy
|
February 7, 2017
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens
Nicola Coppola, Stefania De Pascalis, Vincenzo Messina, et al.
Diabetes Research and Clinical Practice
|
September 5, 2025
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 21, 2023
Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
Riccardo Nevola, Giovanni Feola, Rachele Ruocco, et al.
BMC Medicine
|
March 3, 2026
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study
Celestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
Frontiers in Oncology
|
May 16, 2020
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study
Massimiliano Berretta, Luca Rinaldi, Rosaria Taibi, et al.
European Heart Journal. Imaging Methods and Practice
|
November 21, 2025
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use
Raffaele Marfella, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
International Journal of Molecular Sciences
|
October 29, 2025
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study
Celestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
Drugs in Context
|
January 7, 2021
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study
Rodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, et al.
Cancers
|
June 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis
Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora, et al.
Page
of 24